SAMC
EGRX

Shinko Asset Management Company’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Shinko Asset Management Company’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$669K Sell
9,550
-2,911
-23% -$161K ﹤0.01% 230
2016
Q2 		$483K Hold
12,461
– – ﹤0.01% 238
2016
Q1 		$505K Hold
12,461
– – ﹤0.01% 211
2015
Q4 		$1.1M Buy
12,461
+4,260
+52% +$336K 0.01% 190
2015
Q3 		$607K Buy
+8,201
New +$682K 0.01% 207

Other funds holding EGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

Shinko Asset Management Company's EGRX Position: Q3 2016 in Review

Shinko Asset Management Company reduced its Eagle Pharmaceuticals, Inc. (EGRX) stake by 23% in Q3 2016, selling an estimated $161K and leaving 9,550 shares worth $669K. The position accounts for ﹤0.01% of the portfolio, ranked #230.

Shinko Asset Management Company first reported a position in EGRX in Q3 2015 and has held it in 5 quarters since. The position peaked at $1.1M in Q4 2015. 137 funds tracked by Wall St. Rank hold EGRX as of Q3 2016.

  • Shinko Asset Management Company held 9,550 shares of Eagle Pharmaceuticals, Inc. worth $669K as of Q3 2016.
  • Shinko Asset Management Company sold 2,911 Eagle Pharmaceuticals, Inc. shares in Q3 2016, an estimated $161K.
  • Eagle Pharmaceuticals, Inc. made up ﹤0.01% of Shinko Asset Management Company's portfolio in Q3 2016, its #230 holding.
  • Shinko Asset Management Company first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2015 and has held it in 5 quarters since.
  • Shinko Asset Management Company's Eagle Pharmaceuticals, Inc. position peaked at $1.1M in Q4 2015.
  • 137 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2016.

Based on Shinko Asset Management Company's 13F filing for Q3 2016, filed 24 Oct 2016.